ID   LanthaScreen Akt HEK 293E
SY   LanthaScreen AKT HEK293E; LanthaScreen Akt HEK293E
DR   Wikidata; Q98126846
RX   PubMed=19196698;
CC   Characteristics: Transfected with an emGFP-AKT1 construct whose expression is under the control of a CMV promoter.
CC   Transfected with: HGNC; 391; AKT1.
CC   Transfected with: UniProtKB; P42212; GFP (with p.Ser65Thr, p.Ser72Ala, p.Asn149Lys, p.Met153Thr, p.Ile167Thr and p.His231Leu = EmGFP).
CC   Transfected with: UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Transfected with: UniProtKB; P33967; B.cereus Bsr.
CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 30-01-24; Version: 6
RX   PubMed=19196698; DOI=10.1177/1087057108328132;
RA   Carlson C.B., Robers M.B., Vogel K.W., Machleidt T.;
RT   "Development of LanthaScreen cellular assays for key components within
RT   the PI3K/AKT/mTOR pathway.";
RL   J. Biomol. Screen. 14:121-132(2009).